Home Daily Intelligence Tracker
    • Plans Blog Contact
    Amyris Inc logo
    AMRS

    Amyris Inc

    MaveScore 20 Low model confidence
    Last Price US$0.05 As of Updating
    Market Cap US$18.4m Company size context
    7D Performance 4.17% Past 7 days
    1Y Performance 4.17% Past 12 months
    Model Rating
    Historical model output for research review

    Fundamental data date

    Mar 31, 2023

    1199 days old

    Market price date

    Updating

    Refreshing

    Coverage

    13/16

    3 missing model inputs

    Data quality

    Review

    Partial or delayed snapshot

    Transparent research score

    Why the model scores this stock

    MaveScore is a research prioritization score from 0 to 100. It is historical model output for watchlist review, not personalized financial advice.

    MaveScore 20 Low confidence

    Stored data quality

    Freshness and coverage checks

    13/16 Partial or delayed snapshot

    Quality

    14/35 Weak

    Blends latest model rank with profitability and dilution ranks.

    Financial Strength

    6/25 Weak

    Rewards durable profitability, margins, and positive free cash flow.

    Valuation Support

    0/15 Weak

    Favors positive earnings, positive cash flow, and lower multiples.

    Momentum

    0/15 Needs Data

    Momentum needs recent 3-month or 6-month price-change data.

    Shareholder Alignment

    0/10 Weak

    Rewards less dilutive share behavior and enough size for liquid research coverage.

    Positive model output

    More live company inputs are needed before positive research signals can be surfaced.

    Research risks to review

    • Blends latest model rank with profitability and dilution ranks.
    • Rewards durable profitability, margins, and positive free cash flow.
    • Favors positive earnings, positive cash flow, and lower multiples.

    MaveScore uses historical model inputs, stored company fundamentals, and stored price context for research support only. Review missing inputs and business-specific risks before acting. Missing inputs right now include latest price, 3-month price change, 6-month price change.

    Overview Earnings Report Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Statements Financial Ratio
    Dashboard Funda..tals Prediction Screener Map

    Amyris Inc Overview

    Industry: Chemicals

    Sector: Basic Materials

    Amyris, Inc. operates as a biotechnology company in Europe, North America, Asia, South America, and internationally. It creates, manufactures, and commercializes consumer products and ingredient, including clean beauty, personal care, and health and wellness consumer products; and ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. The company markets its products under the Biossance, JVN, Rose Inc., Pipette, Costa Brazil, OLIKA, Purecane, Terasana, MenoLabs, EcoFabulous, Stripes, and 4U by Tia brand names. It has a collaboration and license agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California. Amyris, Inc. operates as a biotechnology company in Europe, North America, Asia, South America, and internationally. It creates, manufactures, and commercializes consumer products and ingredient, including clean beauty, personal care, and health and wellness consumer products; and ingredients to the Read More

    Amyris Inc is evaluated based on the investment philosophy and approach to stock market investing developed by renowned investor Warren Buffett. Companies with high ratings typically exhibit growing earnings, a substantial profit margin, conservative leverage, a consistently high return on equity, and a sustained practice of repurchasing their shares over the years.

    Amyris Inc

    Score

    Reported Results

    No latest earnings report cached yet

    Run the EDGAR earnings refresh to load the latest company-filed earnings release, 10-Q, 10-K, or transcript exhibit for this ticker.

    Recent News



    Earnings Per Share

    Score 4.00/5
    Amyris Inc boasts a high score, as its Earnings Per Share (EPS) has demonstrated consistent growth over the past six years. Notable counterparts in the sector with high scores includes Linde PLC NEWMARKET CORP Sherwin-Williams Co
    In Chemicals industry , PPG Industries Inc , Dow Inc , AdvanSix are companies with high ratings.

    Return on Equity

    Score 3.78/5
    Amyris Inc stands out with a superior score in the Return on Equity (ROE) section, surpassing the sector median value and showcasing its strong performance in this metric. The top companies in the same sector include Linde PLC NEWMARKET CORP Sherwin-Williams Co
    Amyris Inc AMRS US$18.4m
    Linde PLC LIN US$246.2b
    NEWMARKET CO... NEU US$7.0b
    Sherwin-Will... SHW US$82.8b

    Net Margin

    Score 0.52/5
    Amyris Inc olds a low score as its net margin consistently trails below the sector median value and doesn't exhibit continuous growth over the last six years; notable companies in the sector with commendable scores include Linde PLC NEWMARKET CORP Sherwin-Williams Co
    Amyris Inc AMRS US$18.4m
    Linde PLC LIN US$246.2b
    NEWMARKET CO... NEU US$7.0b
    Sherwin-Will... SHW US$82.8b

    Share Buyback

    In Chemicals industry , PPG Industries Inc , Dow Inc , AdvanSix are companies with high ratings.

    Leverage

    Score 1.59/5
    Amyris Inc registers a lower score in the category as a result of its elevated leverage ratio over the past six years compared to the sector median value. Conversely, other companies in the same sector, including Linde PLC NEWMARKET CORP Sherwin-Williams Co have achieved high scores.
    Amyris Inc AMRS US$18.4m
    Linde PLC LIN US$246.2b
    NEWMARKET CO... NEU US$7.0b
    Sherwin-Will... SHW US$82.8b

    Financial Statements

    Company-reported SEC EDGAR facts organized into the three core statements.

    SEC financial statements are temporarily unavailable.

    Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

    Financial Ratio

    Yearly Quarterly

    Financial
    Profitability
    Growth
    Cash Flow
    Financial Health
    Efficiency Ratios

    Amyris Inc logo

    Amyris Inc

    US$0.05

    US$18.4m

    4.17%

    4.17%